Product Name:Methyl 1,4-dioxo-1,2,3,4-tetrahydroisoquinoline-3-carboxylate

IUPAC Name:methyl 1,4-dioxo-1,2,3,4-tetrahydroisoquinoline-3-carboxylate

CAS:91092-92-1
Molecular Formula:C11H9NO4
Purity:97%
Catalog Number:CM245259
Molecular Weight:219.2

Packing Unit Available Stock Price($) Quantity
CM245259-1g in stock șŭș

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:91092-92-1
Molecular Formula:C11H9NO4
Melting Point:-
Smiles Code:O=C1NC(C(OC)=O)C(C2=C1C=CC=C2)=O
Density:
Catalog Number:CM245259
Molecular Weight:219.2
Boiling Point:
MDL No:MFCD03425940
Storage:

Category Infos

Tetrahydroisoquinolines
Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.

Related Products



Product Other Information

Product Overview Methyl 1,4-dioxo-1,2,3,4-tetrahydroisoquinoline-3-carboxylate (91092-92-1) is a chemical compound that has gained significant attention in the scientific community due to its potential therapeutic applications. The compound is synthesized using a multistep process and has been shown to have various biochemical and physiological effects.
Physical Properties Appearance: Methyl 1,4-dioxo-1,2,3,4-tetrahydroisoquinoline-3-carboxylate is a white to beige crystalline powder solid.
Melting Point: When in solid form, it typically has a melting point of around 220-224 °C.

Chemical Properties Methyl 1,4-dioxo-1,2,3,4-tetrahydroisoquinoline-3-carboxylate is a reactive compound, often utilized as a starting material or intermediate in various chemical reactions and synthesis processes.
Synthesis and Application Methyl 1,4-dioxo-1,2,3,4-tetrahydroisoquinoline-3-carboxylate has been shown to have potential therapeutic applications in various fields such as neurology, oncology, and cardiovascular diseases. In neurology, Methyl 1,4-dioxo-1,2,3,4-tetrahydroisoquinoline-3-carboxylate has been shown to have neuroprotective effects and may have potential as a treatment for neurodegenerative diseases such as Alzheimer's and Parkinson's. In oncology, Methyl 1,4-dioxo-1,2,3,4-tetrahydroisoquinoline-3-carboxylate has been shown to have anticancer properties and may have potential as a chemotherapeutic agent. In cardiovascular diseases, Methyl 1,4-dioxo-1,2,3,4-tetrahydroisoquinoline-3-carboxylate has been shown to have vasodilatory effects and may have potential as a treatment for hypertension.